Seeking Alpha

IMGN
  ImmunoGen, Inc. - NASDAQ

8/22/2014, 2:46 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
IMGN vs. ETF Alternatives
Company Description
Immunogen, Inc. is focused on the antibody-based anticancer therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents.
Sector: Healthcare
Industry: Biotechnology
Country: United States